InvestorsHub Logo
Followers 4
Posts 401
Boards Moderated 0
Alias Born 06/09/2011

Re: CNIMBill post# 71850

Friday, 03/05/2021 4:15:20 PM

Friday, March 05, 2021 4:15:20 PM

Post# of 83095
I would add, call it a mistake or prudence. CVSI has been extremely conservative in just about every aspect. Playing it by the book.

Here's some of the things I appreciate as a long:

Staying clear convertible debt to maintain control of outstanding shares
Achieving GRAS (Toxicology)
Maintaining adverse events reporting
Adding a solid advisory board
Adding experienced management, sales and regulatory personnel
Adding new Non-CBD immunity products in advance of the competition - Started in Dec 2019

It's just disappointing the FDA won't clear the path to national distribution for companies doing business the RIGHT WAY.

Hopefully we'll be hearing more on the drug development as FDA claims to be open in that facet.